Does ALPROSTADIL ALFADEX Cause Peripheral arterial occlusive disease? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Peripheral arterial occlusive disease have been filed in association with ALPROSTADIL ALFADEX. This represents 13.3% of all adverse event reports for ALPROSTADIL ALFADEX.
6
Reports of Peripheral arterial occlusive disease with ALPROSTADIL ALFADEX
13.3%
of all ALPROSTADIL ALFADEX reports
1
Deaths
6
Hospitalizations
How Dangerous Is Peripheral arterial occlusive disease From ALPROSTADIL ALFADEX?
Of the 6 reports, 1 (16.7%) resulted in death, 6 (100.0%) required hospitalization.
Is Peripheral arterial occlusive disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALPROSTADIL ALFADEX. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does ALPROSTADIL ALFADEX Cause?
Stevens-johnson syndrome (9)
Sepsis (7)
Toxic epidermal necrolysis (7)
Right ventricular failure (6)
Anal polyp (5)
Blood pressure abnormal (5)
Cardiac dysfunction (5)
Dermatitis allergic (5)
Disease progression (5)
Duodenitis (5)
What Other Drugs Cause Peripheral arterial occlusive disease?
NILOTINIB (319)
METHOTREXATE (120)
ADALIMUMAB (116)
RIVAROXABAN (101)
PONATINIB (90)
IMATINIB (86)
ASPIRIN (77)
ATORVASTATIN (70)
METOPROLOL (70)
CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (63)